About Us
About ToolGen
Leadership Team
Partnership
Recruit
Contact
Research&Development
R&D Program Overview
Platform Technology
Therapeutics
Greenbio Platform
Products&Services
CRISPR/Cas9 Services
Genome Editing Services
Reporter Services
In-Del Analysis Services
ToolGen’s Products
&Services Full List
News&Event
News&Event
Gallery
IR
Stock Quote
Financial Statement
Corporate filings
Customer
Notice
P&S Enquiry
Academic Library
Reference
Ordering
Research & Development
CRISPR/Cas9
Genome Editing
Therapeutics
News & Event
[Notice] 합병계약 해제에 따른 주주 안내문
[Notice]합병계약 해제에 따른 주주 안내문.pdf
2019.08.20
[보도자료] ㈜툴젠, “유전자교정 세포주 개발 및 사업화”를 위해 ㈜엔세이지(nSAGE)와 MOU계약 체결
㈜툴젠의 김종문 대표이사(오른쪽), ㈜엔세이지의 이봉희 대표이사(왼쪽)가 업무협약 체결 후 기념사진을 촬영하고 있다..
2019.08.13
Products & Services
CRISPR/Cas9
Services
Genome Editing
Services
Reporter
Services
In-Del Analysis
Services
Phone
+82-2-873-8168
FAX : +82-2-873-8169
Time : Weekday 08:30 ~ 17:30
Closed on weekends and holidays
Notice
Check out new news
from Toolgen
DataRoom
Download product
documentation from Toolgen
Academic Library
Ordering
P&S enquiry
Location
